A Look At Charles River Laboratories (CRL) Valuation After Recent Share Price Weakness [Yahoo! Finance]
Charles River Laboratories International, Inc. (CRL)
Last charles river laboratories international, inc. earnings: 2/11 07:00 am
Check Earnings Report
US:NYSE Investor Relations:
ir.criver.com
Company Research
Source: Yahoo! Finance
Charles River Laboratories International (CRL) has drawn attention after a period of weak share performance, including a return of about negative 22% over the past 3 months and negative 21% year to date. At a last close of US$159.16 and a market value of about US$7.8b, the contract research specialist continues to generate annual revenue of roughly US$4.0b, alongside a reported net loss of about US$144.3m. See our latest analysis for Charles River Laboratories International. CRL's recent weakness, including a 3 month share price return of about negative 22% and a year to date share price return of about negative 21%, contrasts with a 1 year total shareholder return of about 2%. This suggests shorter term momentum has faded while longer term returns remain modest. If you are reassessing your watchlist after CRL's pullback, this can be a moment to look at other opportunities in healthcare and life sciences, including 34 healthcare AI stocks With CRL trading around US$159.16,
Show less
Read more
Impact Snapshot
Event Time:
CRL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CRL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CRL alerts
High impacting Charles River Laboratories International, Inc. news events
Weekly update
A roundup of the hottest topics
CRL
News
- 1 Value Stock on Our Buy List and 2 We Turn Down [Yahoo! Finance]Yahoo! Finance
- In Vivo Toxicology Market to Surpass USD 25.90 Billion by 2035; Rising Demand for Drug Safety Assessment and Expanding Biologics Pipeline Driving Market Growth – SNS Insider [Yahoo! Finance]Yahoo! Finance
- 3 Reasons CRL is Risky and 1 Stock to Buy Instead [Yahoo! Finance]Yahoo! Finance
- Locus Cell, Taiwan-Based Cell and Gene Therapy CDMO, Signs MoU with Charles River at APAC Biomanufacturing Leadership Summit [Yahoo! Finance]Yahoo! Finance
- Charles River Laboratories International (CRL) Gains on Strong Results and Resilient Drug Outsourcing Demand [Yahoo! Finance]Yahoo! Finance
CRL
Earnings
- 2/18/26 - Beat
CRL
Sec Filings
- 3/31/26 - Form ARS
- 3/31/26 - Form DEF
- 3/26/26 - Form SCHEDULE
- CRL's page on the SEC website